Springer Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Cancer treatment is undergoing revolutionary change through immunotherapeutic advances that harness the body's own immune system to fight tumours. This comprehensive resource explores novel technologies and personalised medicine approaches that are reshaping oncology. The book examines immune checkpoint inhibitors, including breakthrough antibody drugs targeting CTLA-4 and PD-1 cell surface proteins, which have become foundational treatments for multiple solid tumour indications. Ideal for medical practitioners, researchers and healthcare professionals, this Springer publication provides essential clinical insights into how immunotherapeutic drug development is transforming cancer care and expanding treatment options across diverse cancer types.